In its second wind as a company, Esperion Therapeutics (once owned by Pfizer) has just collected $33 million to continue with clinical trials of its cholesterol-lowering drug.Plymouth, Michigan-based Esperion is ...
Read more
While venture capitalists are usually focused on investing in innovation, this healthcare VC is turning the tables and doing some creative thinking of its own.Last week, life sciences venture firm ...
Read more
Despite the many avenues for treating pain these days, the Institute of Medicine estimates that it costs the U.S. a whopping $635 billion annually in medical charges and lost productivity. ...
Read more
The hypertension treatment market is hot, with Medtronic leading the way in commercializing a renal denervation device. An estimated two dozen other companies are chasing the medical device heavyweight using ...
Read more
A clinical-stage pharmaceutical company with a vaccine it says uses a single antigen to protect against both fungal and bacterial infections is looking for a series B round to fund ...
Read more
February 22, 2011 9:21 am by Frank Vinluan | 0 Comments
Early stage biotech companies looking for venture capital have always found it hard to get VC funding, but it looks like it's only going to get harder. A panel of ...
Read more
Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea (OSA), has named Charles McKhann as its new CEO.McKhann, who previously served as a global vice ...
Read more
February 17, 2010 4:45 pm by Brandon Glenn | 0 Comments
Esperion Therapeutics Inc., a spin-off from Pfizer Inc., has raised an additional $5 million to develop drugs that treat cardiovascular and metabolic disease, according to a SEC filing. The regulatory ...
Read more
August 10, 2009 2:09 pm by Chris Seper | 0 Comments
Venture fund Domain Associates has closed a $500 million fund to invest in early-stage drug and medical device companies with "meaningful portion of its efforts going towards the diagnostics and ...
Read more
Dr. A. Michael Lincoff is part of a new nine-member medical advisory board at Regado Biosciences, a New Jersey company developing a quickly reversible anti-clotting drugs to help with heart ...
Read more
